Arbutus Biopharma Corporation ABUS Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on trailing twelve months.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's return on invested capital?
- Arbutus Biopharma Corporation (ABUS) reported return on invested capital of 111.6% in Q1 2026.
- How has Arbutus Biopharma Corporation's return on invested capital changed year-over-year?
- Arbutus Biopharma Corporation's return on invested capital increased by 178.6% year-over-year, from -141.9% to 111.6%.
- What is the long-term trend for Arbutus Biopharma Corporation's return on invested capital?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's return on invested capital has grown at a -12.0% compound annual growth rate (CAGR), from -119.2% to -62.7%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.